KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Joohyuk Sohn
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 14건 중 1-14 번을 표시중입니다.
1
Article
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young-Woong Won
;
Jin-Hyoung Kang
;
Jung Hye Kwon
;
et al
2023
2
Article
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
정경해
;
Cassandra Slader
;
Chien-Ting Liu
;
et al
2021
3
Article
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
정경해
;
Cassandra Slader
;
Chien-Ting Liu
;
et al
2021
4
Article
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
Dae-Won Lee
;
Bhumsuk Keam
;
Keun Seok Lee
;
et al
2023
5
Article
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim
;
Seock-Ah Im
;
Koung Jin Suh
;
et al
2023
6
Article
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
정경해
;
Jee Hyun Kim 7
;
Ji-Yeon Kim
;
et al
2020
7
Article
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer
Min Hwan Kim
;
Gun Min Kim
;
Jin Mo Ahn
;
et al
2023
8
Article
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
Seul-Gi Kim
;
Min Hwan Kim
;
Sejung Park
;
et al
2023
9
Article
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
Jieun Lee
;
Keun Seok Lee
;
Sung Hoon Sim
;
et al
2023
10
Article
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
정경해
;
Andreas Koehler
;
Anh Nguyen Duc
;
et al
2020
11
Article
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)
Sung Hoon Sim
;
Jeong Eun Kim
;
Min Hwan Kim
;
et al
2022
12
Article
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial.
김성배
;
Annabel Goodwin
;
Joohyuk Sohn
;
et al
2021
13
Article
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi
;
William Jacot
;
Toshinari Yamashita
;
et al
2022
14
Article
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Yen-Shen Lu
;
Seock-Ah Im
;
Marco Colleoni
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide